Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
38461064 | 0 | Di Nisio M, Lee AY. Direct oral anticoagulants: The new standard of care for cancer associated thrombosis. Eur J Intern Med. 2024 Mar 8:S0953-6205(24)00095-5. doi: 10.1016/j.ejim.2024.03.005. | |
38301711 | 0 | Cohen A, Wallenhorst C, Rivera M, et al. Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study. Thromb Haemost. 2024 Feb 1. doi: 10.1055/a-2259-0662. | |
37757472 | 0 | Navi BB, Zhang C, Kaiser JH, et al. Cancer and the Risk of Perioperative Arterial Ischemic Events. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 26:qcad057. doi: 10.1093/ehjqcco/qcad057. | |
37675613 | 0 | Field TS, Dizonno V, Almekhlafi MA, et al. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. Stroke. 2023 Sep 7. doi: 10.1161/STROKEAHA.123.044113. | |
37583314 | 0 | Caroti KS, Khorana AA, Becattini C, et al. Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231189282. doi: 10.1177/10760296231189282. | |
37435565 | 0 | Caroti KS, Becattini C, Carrier M, et al. Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding. TH Open. 2023 Jul 10;7(3):e206-e216. doi: 10.1055/s-0043-1770783. eCollection 2023 Jul. | |
37144109 | 0 | Coleman CI, Caroti KS, Abdelgawwad K, et al. Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism. JACC CardioOncol. 2023 Feb 7;5(2):189-200. doi: 10.1016/j.jaccao.2022.10.014. eCollection 2023 Apr. | |
37075273 | 0 | Key NS, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2023 Apr 19:JCO2300294. doi: 10.1200/JCO.23.00294. | |
35611985 | 0 | Sanfilippo KM, Moik F, Candeloro M, et al. Unanswered questions in cancer-associated thrombosis. Br J Haematol. 2022 May 25. doi: 10.1111/bjh.18276. | |
35599706 | 0 | Lai CMB, Lee AYY, Parkin SBI. Vaccine-induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report. Res Pract Thromb Haemost. 2022 May 18;6(4):e12716. doi: 10.1002/rth2.12716. eCollection 2022 May. | |
35201292 | 0 | Lee AY, Al Moosawi M, Peterson EA, et al. Clinical Care Pathway for Suspected Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 vaccination. Blood Adv. 2022 Feb 24. pii: 484151. doi: 10.1182/bloodadvances.2021006862. | |
35177631 | 0 | Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022 Feb 17;8(1):11. doi: 10.1038/s41572-022-00336-y. | |
34940092 | 0 | Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453. | |
34877446 | 0 | Maraveyas A, Beyer-Westendorf J, Lee AY, et al. Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomes. Res Pract Thromb Haemost. 2021 Nov 30;5(8):e12604. doi: 10.1002/rth2.12604. eCollection 2021 Dec. | |
34649864 | 0 | Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. | |
34604803 | 0 | Davis MK, Lim H, Lee AYY. Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation. JACC CardioOncol. 2021 Sep 21;3(3):425-427. doi: 10.1016/j.jaccao.2021.07.003. eCollection 2021 Sep. | |
34479364 | 0 | Schmidt RA, Lee AY. How I treat and prevent venous thrombotic complications in patients with lymphoma. Blood. 2021 Sep 3. pii: S0006-4971(21)01557-3. doi: 10.1182/blood.2019003689. | |
34332213 | 0 | Cohen AT, Maraveyas A, Beyer-Westendorf J, et al. Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study. Thromb Res. 2021 Oct;206:1-4. doi: 10.1016/j.thromres.2021.06.021. Epub 2021 Jul 2. | |
33812338 | 0 | Becattini C, Di Nisio M, Franco L, et al. Treatment of venous thromboembolism in cancer patients: The dark side of the moon. Cancer Treat Rev. 2021 May;96:102190. doi: 10.1016/j.ctrv.2021.102190. Epub 2021 Mar 23. | |
33691765 | 0 | Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0. | |
33582956 | 0 | Lai CMB, Smith T, Lee AYY. Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series. J Thromb Thrombolysis. 2021 Apr;51(3):725-733. doi: 10.1007/s11239-020-02320-3. Epub 2021 Feb 13. | |
33570602 | 0 | Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442. | |
32877956 | 0 | Picker N, Lee AY, Cohen AT, et al. Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study). Thromb Haemost. 2021 Feb;121(2):206-215. doi: 10.1055/s-0040-1714739. Epub 2020 Sep 2. | |
32838111 | 0 | Rosovsky RP, Sanfilippo KM, Wang TF, et al. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9. pii: RTH212414. doi: 10.1002/rth2.12414. | |
32736774 | 0 | Selby R, Duffy ER, Berny-Lang MA, et al. Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis. Thromb Res. 2020 Jul;191 Suppl 1:S26-S30. doi: 10.1016/S0049-3848(20)30393-5. | |
32548552 | 0 | Bauersachs R, Khorana AA, Lee AYY, et al. Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban. Res Pract Thromb Haemost. 2020 Apr 4;4(4):532-549. doi: 10.1002/rth2.12327. eCollection 2020 May. | |
32320170 | 0 | Holbrook A, Morrow R, Lee AYY, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. J Popul Ther Clin Pharmacol. 2020 Apr 13;27(2):e28-e44. doi: 10.15586/jptcp.v27i2.662. | |
32289865 | 0 | Abdulla A, Davis WM, Ratnaweera N, et al. A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer. Thromb Haemost. 2020 Apr;120(4):702-713. doi: 10.1055/s-0040-1708481. Epub 2020 Apr 14. | |
32223115 | 0 | Lee AYY. Anticoagulant Therapy for Venous Thromboembolism in Cancer. N Engl J Med. 2020 Apr 23;382(17):1650-1652. doi: 10.1056/NEJMe2004220. Epub 2020 Mar 29. | |
32171947 | 0 | Schmidt RA, Al Zaki A, Desilet N, et al. Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism. Thromb Res. 2020 Apr;188:106-114. doi: 10.1016/j.thromres.2020.02.005. Epub 2020 Feb 13. | |
32150614 | 0 | Lee AYY. The changing landscape of anticoagulation in cancer-associated thrombosis. Blood Adv. 2020 Mar 10;4(5):969. doi: 10.1182/bloodadvances.2019000842. | |
31989097 | 0 | Noble S, Nelson A, Scott J, et al. Patient Experience of Living With Cancer-Associated Thrombosis in Canada (PELICANADA). Res Pract Thromb Haemost. 2019 Oct 21;4(1):154-160. doi: 10.1002/rth2.12274. eCollection 2020 Jan. | |
31808866 | 0 | Peterson EA, Lee AYY. Update from the clinic: what's new in the diagnosis of cancer-associated thrombosis? Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):167-174. doi: 10.1182/hematology.2019000024. | |
31382307 | 0 | Suryanarayan D, Lee AYY, Wu C. Direct Oral Anticoagulants in Cancer Patients. Semin Thromb Hemost. 2019 Sep;45(6):638-647. doi: 10.1055/s-0039-1693479. Epub 2019 Aug 5. | |
31381464 | 0 | Key NS, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5. | |
31380891 | 0 | Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. | |
30859370 | 0 | Woodruff S, Lee AYY, Carrier M, et al. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study. J Thromb Thrombolysis. 2019 May;47(4):495-504. doi: 10.1007/s11239-019-01833-w. | |
30511879 | 0 | Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. | |
30349884 | 0 | Samuelson Bannow BR, Lee AYY, Khorana AA, et al. Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Res Pract Thromb Haemost. 2018 Jun 19;2(4):664-669. doi: 10.1002/rth2.12111. eCollection 2018 Oct. | |
30186045 | 0 | Cohen AT, Maraveyas A, Beyer-Westendorf J, et al. COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study. Thromb J. 2018 Sep 4;16:21. doi: 10.1186/s12959-018-0176-2. eCollection 2018. | |
30014300 | 0 | Htun KT, Ma MJY, Lee AYY. Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen. J Thromb Thrombolysis. 2018 Oct;46(3):386-392. doi: 10.1007/s11239-018-1711-5. | |
29680102 | 0 | Lloyd AJ, Dewilde S, Noble S, et al. What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life? Value Health. 2018 Apr;21(4):449-455. doi: 10.1016/j.jval.2017.09.015. Epub 2017 Nov 10. | |
29618162 | 0 | Bauersachs R, Lee AYY, Kamphuisen PW, et al. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study. Thromb Haemost. 2018 May;118(5):914-921. doi: 10.1055/s-0038-1641150. Epub 2018 Apr 4. | |
29307469 | 0 | Lee AYY. Overview of VTE treatment in cancer according to clinical guidelines. Thromb Res. 2018 Apr;164 Suppl 1:S162-S167. doi: 10.1016/j.thromres.2018.01.002. Epub 2018 Jan 3. | |
29222247 | 0 | Lee AYY. When can we stop anticoagulation in patients with cancer-associated thrombosis? Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):128-135. doi: 10.1182/asheducation-2017.1.128. | |
29212805 | 0 | Lee AYY. When can we stop anticoagulation in patients with cancer-associated thrombosis? Blood. 2017 Dec 7;130(23):2484-2490. doi: 10.1182/blood-2017-05-787929. Epub 2017 Dec 6. | |
29212129 | 0 | Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6. | |
28597460 | 0 | Htun KT, Lee AYY. Thromboprophylaxis in Cancer Patients Undergoing Surgery. Semin Thromb Hemost. 2017 Oct;43(7):672-681. doi: 10.1055/s-0037-1602666. Epub 2017 Jun 8. | |
28481706 | 0 | Khorana AA, Janas M, Jarner MF, et al. Reply to R. Fonseca et al. J Clin Oncol. 2017 Jul 1;35(19):2218-2219. doi: 10.1200/JCO.2017.72.8246. Epub 2017 May 8. | |
28029329 | 0 | Khorana AA, Kamphuisen PW, Meyer G, et al. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial. J Clin Oncol. 2017 Apr 1;35(10):1078-1085. doi: 10.1200/JCO.2016.67.4564. Epub 2016 Dec 28. | |
27884850 | 0 | Holbrook A, Dormuth C, Morrow R, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. BMJ Open. 2016 Nov 24;6(11):e013263. doi: 10.1136/bmjopen-2016-013263. | |
27809948 | 0 | Field TS, Camden MC, Al-Shimemeri S, et al. Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologist and Hematologist Respondents in a Canadian Survey. Can J Neurol Sci. 2017 Jan;44(1):116-119. doi: 10.1017/cjn.2016.297. Epub 2016 Nov 4. | |
27067964 | 0 | Lee AY, Peterson EA, Wu C. Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology. Thromb Res. 2016 Apr;140 Suppl 1:S119-27. doi: 10.1016/S0049-3848(16)30110-4. | |
26887853 | 0 | Fagarasanu A, Alotaibi GS, Hrimiuc R, et al. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2016 May;23(5):1422-30. doi: 10.1245/s10434-016-5127-1. Epub 2016 Feb 17. | |
26780740 | 0 | Khorana AA, Carrier M, Garcia DA, et al. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):81-91. doi: 10.1007/s11239-015-1313-4. | |
26763915 | 0 | Field TS, Camden MC, Al-Shimemeri S, et al. Off-label use of novel anticoagulants for treatment of cerebral venous thrombosis: A Canadian survey. Int J Stroke. 2017 Dec;12(9):NP16-NP18. doi: 10.1177/1747493015616643. Epub 2016 Jan 12. | |
26757472 | 0 | Khorana AA, Lee AY. Tinzaparin vs Warfarin for Acute Venous Thromboembolism--Reply. JAMA. 2016 Jan 12;315(2):200-1. doi: 10.1001/jama.2015.15070. | |
26369828 | 0 | Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015 Sep 15;163(6 Suppl):S1-40. doi: 10.7326/M15-0744. | |
26284719 | 0 | Lee AYY, Kamphuisen PW, Meyer G, et al. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial. JAMA. 2015 Aug 18;314(7):677-686. doi: 10.1001/jama.2015.9243. | |
26095467 | 0 | Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22. | |
25966905 | 0 | Schulman S, Carrier M, Lee AY, et al. Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation. 2015 Jul 21;132(3):167-73. doi: 10.1161/CIRCULATIONAHA.115.015688. Epub 2015 May 12. | |
25926600 | 0 | Linkins LA, Bates SM, Lee AY, et al. Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study. Blood. 2015 Jul 30;126(5):597-603. doi: 10.1182/blood-2014-12-618165. Epub 2015 Apr 29. | |
25682086 | 0 | Wu C, Lee AY. Novel or non-vitamin K antagonist oral anticoagulants and the treatment of cancer-associated thrombosis. Semin Thromb Hemost. 2015 Mar;41(2):237-43. doi: 10.1055/s-0035-1544160. Epub 2015 Feb 15. | |
25605844 | 0 | Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20. | |
25190031 | 0 | Kopolovic I, Lee AY, Wu C. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Ann Hematol. 2015 Feb;94(2):329-36. doi: 10.1007/s00277-014-2198-6. Epub 2014 Sep 5. |